Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Correct I do assume there has been no buyout discussion, but if there have been, then they have been discussed in the $5-10 range. Who would bring a 20 offer to the table on a 3 company when they could take that offer to the shareholders directly? If ADXS wants 20 and the buyer wants to pay 10, well then the discussion pretty much ends there. If BO talks have ever occurred, then why have they never mentioned it, why has no analyst ever mentioned ADXs is prime for a BO, why has no Institutional interest caught wind of this and caused a feeding frenzy, and why have shorts held their short position even at all-time lows if there was any merit to the company ever getting a BO offer or even having a discussion? The BOD does not want a 10 offer but the buyer will not want to pay 20 right now. Pretty straight forward really. False, small biotech companies can carry high values, based on the assumption and likely hood of future value. Basic math. If ADXS has a 50% chance of $1B in sales in 2020, then this would not be valued where it is today.

A company entertaining BO ideas at all-time lows is laughable and would look incredibly week! They don’t even know where they are going to get funding for their salaries in 12 months but they in talks with BP for a Billion $ BO? Pure delusional!